These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 21832933)

  • 1. IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation.
    Forthal DN; Landucci G; Ding H; Kappes JC; Wang A; Thung I; Phan T
    AIDS; 2011 Nov; 25(17):2099-104. PubMed ID: 21832933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects.
    Raux M; Finkielsztejn L; Salmon-Céron D; Bouchez H; Excler JL; Dulioust E; Grouin JM; Sicard D; Blondeau C
    AIDS Res Hum Retroviruses; 2000 Apr; 16(6):583-94. PubMed ID: 10777149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine.
    McGuire EP; Fong Y; Toote C; Cunningham CK; McFarland EJ; Borkowsky W; Barnett S; Itell HL; Kumar A; Gray G; McElrath MJ; Tomaras GD; Permar SR; Fouda GG
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29021402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant gp120 vaccine-induced antibodies inhibit clinical strains of HIV-1 in the presence of Fc receptor-bearing effector cells and correlate inversely with HIV infection rate.
    Forthal DN; Gilbert PB; Landucci G; Phan T
    J Immunol; 2007 May; 178(10):6596-603. PubMed ID: 17475891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1MN recombinant glycoprotein 160 vaccine-induced cellular and humoral immunity boosted by HIV-1MN recombinant glycoprotein 120 vaccine. National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
    Gorse GJ; Corey L; Patel GB; Mandava M; Hsieh RH; Matthews TJ; Walker MC; McElrath MJ; Berman PW; Eibl MM; Belshe RB
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):115-32. PubMed ID: 10029244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody to native human immunodeficiency virus type 1 envelope glycoproteins induced by IIIB and MN recombinant gp120 vaccines. The NIAID AIDS Vaccine Evaluation Group.
    Gorse GJ; Patel GB; Newman FK; Belshe RB; Berman PW; Gregory TJ; Matthews TJ
    Clin Diagn Lab Immunol; 1996 Jul; 3(4):378-86. PubMed ID: 8807200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MN and IIIB recombinant glycoprotein 120 vaccine-induced binding antibodies to native envelope glycoprotein of human immunodeficiency virus type 1 primary isolates. National Institute of Allergy and Infectious Disease Aids Vaccine Evaluation Group.
    Gorse GJ; Patel GB; Mandava M; Berman PW; Belshe RB
    AIDS Res Hum Retroviruses; 1999 Jul; 15(10):921-30. PubMed ID: 10408729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential IgG subclass responses to epitopes in transmembrane protein of HIV-1.
    Klasse PJ; Blomberg J; Pipkorn R
    Viral Immunol; 1990; 3(2):89-98. PubMed ID: 1694431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Antibody Responses Induced by RV144, VAX003, and VAX004 Vaccination Regimens.
    Karnasuta C; Akapirat S; Madnote S; Savadsuk H; Puangkaew J; Rittiroongrad S; Rerks-Ngarm S; Nitayaphan S; Pitisuttithum P; Kaewkungwal J; Tartaglia J; Sinangil F; Francis DP; Robb ML; de Souza MS; Michael NL; Excler JL; Kim JH; O'Connell RJ; Karasavvas N
    AIDS Res Hum Retroviruses; 2017 May; 33(5):410-423. PubMed ID: 28006952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Stable MGAT1
    Doran RC; Yu B; Wright M; O'Rourke SM; Yin L; Richardson JM; Byrne G; Mesa KA; Berman PW
    Front Immunol; 2018; 9():2313. PubMed ID: 30344523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological and virological analyses of persons infected by human immunodeficiency virus type 1 while participating in trials of recombinant gp120 subunit vaccines.
    Connor RI; Korber BT; Graham BS; Hahn BH; Ho DD; Walker BD; Neumann AU; Vermund SH; Mestecky J; Jackson S; Fenamore E; Cao Y; Gao F; Kalams S; Kunstman KJ; McDonald D; McWilliams N; Trkola A; Moore JP; Wolinsky SM
    J Virol; 1998 Feb; 72(2):1552-76. PubMed ID: 9445059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV-1 antibody-dependent cellular cytotoxicity mediated by hyperimmune bovine colostrum IgG.
    Kramski M; Lichtfuss GF; Navis M; Isitman G; Wren L; Rawlin G; Center RJ; Jaworowski A; Kent SJ; Purcell DF
    Eur J Immunol; 2012 Oct; 42(10):2771-81. PubMed ID: 22730083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.
    Hayes JM; Frostell A; Cosgrave EF; Struwe WB; Potter O; Davey GP; Karlsson R; Anneren C; Rudd PM
    J Proteome Res; 2014 Dec; 13(12):5471-85. PubMed ID: 25345863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin class and subclass antibodies to HIV proteins in maternal serum: association with perinatal transmission.
    Mann DL; Hamlin-Green G; Willoughby A; Landesman SH; Goedert JJ
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):617-22. PubMed ID: 7513762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG subclass profiles in infected HIV type 1 controllers and chronic progressors and in uninfected recipients of Env vaccines.
    Banerjee K; Klasse PJ; Sanders RW; Pereyra F; Michael E; Lu M; Walker BD; Moore JP
    AIDS Res Hum Retroviruses; 2010 Apr; 26(4):445-58. PubMed ID: 20377426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
    Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
    Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the specificities of IgG, IgG-subclass, IgA and IgM reactivities in African and European HIV-infected individuals with an HIV-1 clade C proteome-based array.
    Gallerano D; Ndlovu P; Makupe I; Focke-Tejkl M; Fauland K; Wollmann E; Puchhammer-Stöckl E; Keller W; Sibanda E; Valenta R
    PLoS One; 2015; 10(2):e0117204. PubMed ID: 25658330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal powder immunization with a recombinant HIV gp120 targets Langerhans cells and induces enhanced immune responses.
    Chen D; Zuleger C; Chu Q; Maa YF; Osorio J; Payne LG
    AIDS Res Hum Retroviruses; 2002 Jul; 18(10):715-22. PubMed ID: 12167279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel assay for detecting virus-specific antibodies triggering activation of Fcγ receptors.
    Corrales-Aguilar E; Trilling M; Reinhard H; Mercé-Maldonado E; Widera M; Schaal H; Zimmermann A; Mandelboim O; Hengel H
    J Immunol Methods; 2013 Jan; 387(1-2):21-35. PubMed ID: 23023090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of immunoglobulin G subclass reactivity to HIV-1 envelope peptides in children born to HIV-1-infected mothers.
    Jansson M; Wahren B; Scarlatti G; Principi N; Lombardi V; Livadiotti S; Elia L; Plebani A; Wigzell H; Rossi P
    AIDS; 1992 Apr; 6(4):365-71. PubMed ID: 1616634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.